Monsanto Company is facing a new product liability claim alleging non-Hodgkin’s lymphoma from Roundup. The plaintiff claims the company failed to warn him of this alleged correlation.
Plaintiff Randall V. and his wife Debra V. allege Randall developed lymphoma from Roundup after learning of the alleged correlation between the weedkiller and cancer development.
According to the Roundup cancer lawsuit, Randall used the weedkiller on a regular basis for years and followed all safety instructions provided on the label. However, Randall was reportedly diagnosed with non-Hodgkin’s lymphoma in 2016 and has since been contending with the condition.
Randall alleges he discovered the association between non-Hodgkin’s lymphoma from Roundup use after a recent announcement from the International Agency for Research on Cancer (IARC) pointed out a potential correlation.
Overview of Non Hodgkin’s Lymphoma from Roundup Correlation
The IARC released a report in March 2015 which concluded that Roundup’s main ingredient glyphosate may be linked to cancer. The IARC also stated that four other pesticides may be linked to cancer.
The IARC released this report after reviewing the results of several Roundup studies published in Canada, United States and Sweden:
- Canadian Study: Published in the American Association for Cancer Research in November 2001, with researchers finding that subjects exposed to glyphosate were developing non-Hodgkin’s lymphoma in under 10 years after exposure.
- United States Study: Published in the Occupation and Environmental Medicine journal, researchers concluded that glyphosate and certain other pesticides were “potentially carcinogenic” and was “associated with increased NHL [non-Hodgkin’s Lymphoma] incidence.”
- Swedish Study: Published in the International Journal of Cancer in October 2008, which reportedly found that the risk of non Hodgkin’s lymphoma from Roundup doubled in less than 10 years after exposure.
Researchers reportedly began exploring the possibility of lymphoma from Roundup after it was noted that a number of farmers were diagnosed with non-Hodgkin’s lymphoma.
The Environmental Protection Agency (EPA) reportedly began to speculate the correlation in the 1980s, with Monsanto making Roundup available for over 40 years. During this time, Monsanto allegedly marketed Roundup as a safe and effective product and did not mention the potential carcinogenic effects.
Roundup is currently one of the most popularly used pesticides in the United States, with millions of gallons used to treat private lawns as well as commercial nurseries. The active ingredient glyphosate is supposed to give consumers the ability to eliminate unwanted weeds, while promoting healthy plant growth.
Glyphosate is a selective herbicide, which targets plant life with specific enzymes and stops them from reproducing. With glyphosate’s recent association with non-Hodgkin’s lymphoma, consumers should be vigilant against any unexplained symptoms.
Randall and Debra’s Roundup lawsuit is seeking multiple damages against Monsanto, including counts of negligence, loss of consortium, and failure to warn. Randall states he would not have used the weedkiller if he knew he could potentially develop non-Hodgkin’s lymphoma from Roundup use.
This Roundup Cancer Lawsuit is Case No. 4:18-cv-01063-JAR, in the U.S. District Court of Eastern Missouri, Eastern Division.
If you or a loved one developed cancer after using Roundup as a farm worker or home gardener, you may have a legal claim. Legal migrant farm workers may also seek help. Learn more by filling out the form on this page for a FREE case evaluation.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Roundup Cancer Class Action Lawsuit Investigation
For the most up-to-date information on this case, click here.